Steward Partners Investment Advisory’s Pulse Biosciences PLSE Stock Holding History

Steward Partners Investment Advisory’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.84K	Hold	178	–	–	﹤0.01%	3876
2025 Q4	$2.44K	Hold	178	–	–	﹤0.01%	3910
2025 Q3	$3.15K	Hold	178	–	–	﹤0.01%	3789
2025 Q2	$2.69K	Sell	178 -260	-59%	-$4.31K	﹤0.01%	3668
2025 Q1	$7.05K	Hold	438	–	–	﹤0.01%	3257
2024 Q4	$7.63K	Hold	438	–	–	﹤0.01%	3213
2024 Q3	$7.68K	Hold	438	–	–	﹤0.01%	3050
2024 Q2	$4.9K	Buy	438 +260	+146%	+$2.45K	﹤0.01%	3054
2024 Q1	$1.55K	Hold	178	–	–	﹤0.01%	3327
2023 Q4	$2.18K	Hold	178	–	–	﹤0.01%	3186
2023 Q3	$717	Hold	178	–	–	﹤0.01%	3222
2023 Q2	$1.28K	Hold	178	–	–	﹤0.01%	3098
2023 Q1	$598	Hold	178	–	–	﹤0.01%	3161
2022 Q4	$493	Hold	178	–	–	﹤0.01%	3197
2022 Q3	$0	Hold	178	–	–	﹤0.01%	3344
2022 Q2	$0	Hold	178	–	–	﹤0.01%	3337
2022 Q1	$1K	Sell	178 -1,050	-86%	-$8.59K	﹤0.01%	3211
2021 Q4	$18K	Sell	1,228 -1,647	-57%	-$32.8K	﹤0.01%	2371
2021 Q3	$62K	Buy	2,875 +2,125	+283%	+$45.7K	﹤0.01%	1778
2021 Q2	$12K	Hold	750	–	–	﹤0.01%	5728
2021 Q1	$17.8K	Hold	750	–	–	﹤0.01%	2531
2020 Q4	$18K	Hold	750	–	–	﹤0.01%	2100
2020 Q3	$9K	Buy	750 +50	+7%	+$538	﹤0.01%	2183
2020 Q2	$7K	Hold	700	–	–	﹤0.01%	2173
2020 Q1	$5K	Sell	700 -1,500	-68%	-$15.6K	﹤0.01%	2088
2019 Q4	$29K	Sell	2,200 -2,000	-48%	-$28.5K	﹤0.01%	1641
2019 Q3	$64K	Hold	4,200	–	–	﹤0.01%	1260
2019 Q2	$55K	Buy	+4,200	New	+$57.3K	﹤0.01%	1302
2018 Q4	–	Sell	-2,665	Closed	-$38K	–	1767
2018 Q3	$38K	Sell	2,665 -1,000	-27%	-$14.2K	﹤0.01%	1305
2018 Q2	$55K	Hold	3,665	–	–	﹤0.01%	1069
2018 Q1	$49K	Buy	3,665 +1,000	+38%	+$19K	﹤0.01%	1012
2017 Q4	$62K	Hold	2,665	–	–	﹤0.01%	763
2017 Q3	$49K	Sell	2,665 -1,015	-28%	-$23.1K	0.01%	699
2017 Q2	$127K	Buy	+3,680	New	+$101K	0.01%	464

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Steward Partners Investment Advisory's PLSE Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Pulse Biosciences (PLSE) position steady in Q1 2026 at 178 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #3876.

Steward Partners Investment Advisory first reported a position in PLSE in Q2 2017 and has held it in 34 quarters since. The position peaked at $127K in Q2 2017. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

Steward Partners Investment Advisory held 178 shares of Pulse Biosciences worth $3.84K as of Q1 2026.
Steward Partners Investment Advisory left its Pulse Biosciences share count unchanged in Q1 2026.
Pulse Biosciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3876 holding.
Steward Partners Investment Advisory first reported a position in Pulse Biosciences in Q2 2017 and has held it in 34 quarters since.
Steward Partners Investment Advisory's Pulse Biosciences position peaked at $127K in Q2 2017.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.